BridgeMD
New treatment option for Spinal Cord Injury
Official title Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury
ClinicalTrials.gov ID: NCT07343583
What this study is testing
- What it's testing
- Suprasacral spinal cord injury (SCI) frequently leads to neurogenic detrusor overactivity (NDO), resulting in elevated bladder storage pressures, urinary incontinence, and an increased risk of upper urinary tract damage. Early regulation of bladder function is a key objective of SCI rehabilitation, particularly during the subacute phase when pathological spinal reflex pathways are still developing.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- ≥18-65 years of age
- Injury duration \<6 months
- Traumatic and non-traumatic SCI;
- Patients with spinal cord injury above T11
You likely can't join if
- Patients with a cardiac pacemaker
- Patients with other neurological diseases that may affect neurogenic bladder (Parkinson's disease, polyneuropathy, neurodegenerative disease...
- Patients with structural abnormalities in the genitourinary system (pelvic floor dysfunction, BPH, etc.)
- Patients with acute urinary tract infection
- Patients with a history of pelvic fracture associated with SCI
- Patients using medications that may affect NDO (anticholinergic-sympathomimetic, etc.)
See the full eligibility criteria
- ≥18-65 years of age
- Injury duration \<6 months
- Traumatic and non-traumatic SCI;
- Patients with spinal cord injury above T11
- Patients with a cardiac pacemaker
- Patients with other neurological diseases that may affect neurogenic bladder (Parkinson's disease, polyneuropathy, neurodegenerative disease, cerebrovascular disease, etc.)
- Patients with structural abnormalities in the genitourinary system (pelvic floor dysfunction, BPH, etc.)
- Patients with acute urinary tract infection
- Patients with a history of pelvic fracture associated with SCI
- Patients using medications that may affect NDO (anticholinergic-sympathomimetic, etc.)
- Patients who have undergone another neuromodulation technique after injury
- Patients who have previously undergone pelvic radiation, bladder cancer, or other surgical procedures performed on the bladder that may affect bladder physiology will not be included in the study.
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Çankaya, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Çankaya, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.